News

Healx, an AI-powered, patient-inspired, biotech company, is seeking rare disease therapeutic opportunities from academic, patient groups or (early-stage) biotechs. Healx, along with their partners, aim to quickly turn research into... read more →

Chiesi Global Rare Diseases is seeking research proposals for new technologies from academic medical centres, universities, and research institutions globally. Their objective is to award funds to validate early‐stage projects... read more →

A global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify research related to the generation of T cells, both alpha... read more →

BioMarin Pharmaceutical Inc. is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. BioMarin Pharmaceutical Inc. is looking for expertise in the pathology and... read more →

BioMarin Pharmaceutical Inc. is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. C‐type natriuretic peptide (CNP) is a growth factor with receptors expressed... read more →

A global chemical company, leading in the manufacturing of products for the Composites, Advanced Composites, Adhesives and Functional Polymer markets, is looking for a bioderived thermoplastic-like resin (i.e., liquid at... read more →

A European cellular agriculture company, with an interest in developing cultivated dairy products, are seeking collaborative opportunities involved in improving the fermentation of filamentous fungal strains.  

RHI Magnesita GmbH, a global leader in the refractory industry, is looking to develop or match a green process to convert carbon bonded secondary refractory raw materials into usable materials.... read more →